#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Esomeprazole – S-isomer of omeprazole with more favorable pharmacological properties and stronger pharmacodynamic effect


Authors: M. Lukáš
Authors‘ workplace: Klinické a výzkumné centrum pro střevní záněty ISCARE I. V. F. a.  s., Praha
Published in: Gastroent Hepatol 2018; 72(2): 179-181
Category: Drug Profile
doi: https://doi.org/10.14735/amgh2018179


Sources

1. Martínek J, Lukáš M. Inhibitory protonové pumpy – up to date. Gastroent Hepatol 2011; 65 (6): 331–342.

2. Špičák J. Inhibitory protonové pumpy: vedlejší účinky a interakce. Gastroent Hepatol 2013; 67 (4): 289–297.

3. Souhrn údajů o přípravku Pylera. [online]. Dostupné z: www.sukl.cz.

4. Heribanová L. Extraezofageální a gastroezofageální reflux – vztah k astma bronchiale. Gastroent Hepatol 2016; 70 (5): 438–442. doi: 10.14735/amgh2016438.

5. Olbe L, Carlsson E, Lindberg P. A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole. Nat Rev Drug Discov 2003; 2 (2): 132–139.

6. Miehlke S, Madisch A, Kirsch C et al. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily – a randomized, two-way cros­sover study. Aliment Pharmacol Ther 2005; 21 (8) : 963–967.

Labels
Paediatric gastroenterology Gastroenterology and hepatology Surgery Internal medicine Nutritive therapist Obesitology

Article was published in

Gastroenterology and Hepatology

Issue 2

2018 Issue 2

Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#